Syncona Limited Annual Financial Report (1105R)
25 Giugno 2020 - 1:38PM
UK Regulatory
TIDMSYNC
RNS Number : 1105R
Syncona Limited
25 June 2020
Syncona Limited
Publication of 2020 Annual Report and Notice of Annual General
Meeting
25 June 2020
Syncona Ltd today announces that it has published its Annual
Report and Accounts for the year ended 31 March 2020. In addition,
Syncona has published its Notice of Annual General Meeting
2020.
In compliance with Listing Rule 9.6.1, these documents have
today been submitted to the National Storage Mechanism and will
shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
Copies of these documents, together with the Form of Proxy for
use in connection with the 2020 Annual General Meeting, are
available electronically on Syncona's website at
www.synconaltd.com/investors . Printed copies of these documents
are also being posted to shareholders where requested.
Syncona's Annual General Meeting will be held at 10:30am on 28
July 2020 at the offices of Citco Fund Services (Guernsey) Limited,
Arnold House, St Julian's Avenue, St Peter Port, Guernsey, GY1 3RD.
Given the restrictions arising from the ongoing COVID-19 global
pandemic, shareholders are strongly encouraged to ensure that their
votes are counted at the 2020 Annual General Meeting by appointing
the chair of the 2020 Annual General Meeting as their proxy in line
with the procedures set out in the Notice of Annual General
Meeting.
[ENDS]
Enquiries
Syncona Ltd
Siobhan Weaver / Annabel Clay
Tel : +44 (0) 20 3981 7940
FTI Consulting
Ben Atwell / Natalie Garland-Collins / Tim Stamper
Tel: +44 (0) 20 3727 1000
About Syncona
Syncona is a leading FTSE250 healthcare company focused on
founding, building and funding a portfolio of global leaders in
life science. Our vision is to build a sustainable, diverse
portfolio of 15 - 20 companies focused on delivering
transformational treatments to patients in truly innovative areas
of healthcare, through which we are seeking to deliver strong
risk-adjusted returns for shareholders.
We seek to partner with the best, brightest and most ambitious
minds in science to build globally competitive businesses. We take
a long-term view, underpinned by a strategic capital base which
provides us with control and flexibility over the management of our
portfolio. We focus on delivering dramatic efficacy for patients in
areas of high unmet need.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ACSPPUQWQUPUGGA
(END) Dow Jones Newswires
June 25, 2020 07:38 ET (11:38 GMT)
Grafico Azioni Syncona (LSE:SYNC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Syncona (LSE:SYNC)
Storico
Da Apr 2023 a Apr 2024